MHTX — Manhattan Scientifics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapSucker Stock
- $3.86m
- $4.77m
- $0.05m
Annual balance sheet for Manhattan Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.269 | 0.087 | 0.261 | 0.353 | 0.232 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | — | 0.3 | 0.3 | 0.3 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.278 | 0.098 | 0.574 | 0.665 | 0.547 |
| Net Property, Plant And Equipment | 0.008 | 0.006 | 0.004 | 0.006 | 0.004 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 10.8 | 2.66 | 2.23 | 6.85 | 3.45 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 1.63 | 1.75 | 2.09 | 1.01 | 1.36 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.63 | 1.75 | 2.17 | 1.12 | 1.36 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 9.22 | 0.908 | 0.053 | 5.73 | 2.09 |
| Total Liabilities & Shareholders' Equity | 10.8 | 2.66 | 2.23 | 6.85 | 3.45 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |